Peter Gardiner
Corporate Officer/Principal bei The Royal College of Physicians
Profil
Peter Gardiner is a professional with a doctorate from the University of Leeds, an MBA from Northwestern University, and an undergraduate degree from The University of Texas at Austin.
He is currently a Member at The Royal College of Physicians.
Previously, he held positions such as Marketing Director at Chiron Corp., Senior Medical Officer at Bristol Myers Squibb Co., Vice President-Strategic Marketing at EPIX Pharmaceuticals, Inc., Marketing Manager at Chiron Diagnostics Corp., Chief Business Officer at Interleukin Genetics, Inc., and Principal at Abbott Diagnostics, Inc. He also served as Chief Medical Officer & VP-Medical Affairs at BG Medicine, Inc. from 2009 to 2011.
Aktive Positionen von Peter Gardiner
Unternehmen | Position | Beginn |
---|---|---|
The Royal College of Physicians | Corporate Officer/Principal | 02.02.2010 |
Ehemalige bekannte Positionen von Peter Gardiner
Unternehmen | Position | Ende |
---|---|---|
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Vertrieb & Marketing | - |
Chiron Diagnostics Corp.
Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Vertrieb & Marketing | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | 04.02.2010 |
Ausbildung von Peter Gardiner
Northwestern University | Masters Business Admin |
The University of Texas at Austin | Undergraduate Degree |
University of Leeds | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BG MEDICINE, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private Unternehmen | 5 |
---|---|
Interleukin Genetics, Inc.
Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Chiron Diagnostics Corp.
Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Abbott Diagnostics, Inc.
Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA. | Health Technology |